Other

Arris Enterprises LLC

Jefferson Science Associates, LLC

Timothy S Moore

Cullen Thomas Moore

William K Moore

John R Moore

John J Moore

Joseph J Register

John K Moore

Gregory Gohman

Steven Paul Nolle

Charles Edwin Reece

James Touhey

Embodiments include a method of using inactivated human cold coronaviruses (HCoVs) particularly HCoV-299E, HCoV-OC43, HCoV-NL63 and HCoV-HKU1 as a booster, for the immunization against SARS-CoV-2 infections.

HCoV immunogenic booster composition for improving immunityagainst SARS-COV-2 infection

The present invention in an embodiment relates generally to mask/respirator having a filter assembly detachable therefrom.

Bioburden reduction surgical masks/respirators with use in protection against SARS-CoV-2 infections

A LED panel wherein a plurality thereof are employed to construct a LED volume for filing simulated virtual environments wherein the LED panel of the present invention provides tracking of objects in the vicinity thereof such as but not limited to a camera wherein the tracking elements do not require post production removal. The LED panel includes a housing having a perimeter frame that has a transparent LED display mounted thereto. On the rear surface of the LED display or proximate thereto are a plurality of retroreflectors. The retroreflectors function to provide inside-out tracking of a camera disposed within the LED volume. The present invention further includes a plurality of lidar sensors and optical sensors mounted to the perimeter frame. The lidar sensors and optical sensors provide data for outside-in tracking of a camera within the LED volume. The retroreflectors can be provided in multiple alternate embodiments.

LED panel having integrated infrared retroreflectors for video volume production environments

A bilayer composition for amelioriation of, or prophylaxis against, SARS-CoV-2 infection comprising a: (i) a first layer consisting of 250 mg to 1600 mg of 5-aminolevulinic acid (ALA), or salt thereof, and pharmaceutically acceptable excipients that allow for immediate release of the 5-aminolevulinic acid; (ii) a second layer consisting of hydroxychloroquine (HCQ), and/or a salt thereof, in a dose of 100 mg-1500 mg, or salt thereof, and at least one pharmaceutically acceptable excipient comprising a release modifier for sustained release of the hydroxychloroquine or chloroquine.

Pharmaceutical composition for the treatment of Covid-19 infection

Embodiments include a method of using inactivated human cold coronaviruses (HCoVs) particularly HCoV-299E, HCoV-OC43, HCoV-NL63 and HCoV-HKU1, alone or as a booster, for the immunization against SARS-CoV-2 infections. Vaccine embodiments further comprise HCoV virus envelope subunits which may be in the form of virus-like spheroids (VLS).

HCoV vaccine for improving immunity against SARS-CoV-2 infection

In embodiments there is described a method for reducing false positives and negatives in the detection of SARS-CoV-2 in suspected patients using mass spectroscopy employing the steps of mixing samples of collected saliva and nasopharyngeal secretions in a single sample container; adding universal transport medium to the mixed samples in said single sample container; transporting the single sample container at a temperature above 0&#xb0; C. to a remote location; deactivation of viral content of the mixed sample; protein digestion of the mixed sample; concomitant separation of peptides, ionization by mass spectroscopy of the separated peptides, and comparison of peptide patterns to known SARS-CoV-2 peptides. Also set forth in an embodiment is a collection container for collecting saliva and/or sputum, as well as a swab member, with universal transport medium and/or virus inactivating agent housed in separate compartment communicable with sample compartment through a one-way valve.

Collection system and device for reducing clinical false positives and negatives in the detection of SARS-CoV-2

Method for reducing clinical false positives and negatives in the detection of SARS-CoV-2

Systems and methods can be operable to provide subscription service level based channel assignment for network devices. In some implementations, such systems and methods can operate to create service flow list for use in assigning channels to CPE devices (e.g., modems, eMTAs, STBs, etc.). Such systems and methods can assist in assigning CPE devices to channels that correspond to their subscribed service level, thereby facilitating delivery of the proper level of service.

Channel assignment based on subscribed service level

Hockey helmet window cling

Baseball helmet window cling

Racing helmet window cling

Football helmet window cling

An improved mouth guard designed for use with protective equipment such as helmets and other head gear is disclosed. The invention provides a convenient means to temporarily affix the mouth guard to sports equipment, or other object when the mouth guard is removed, rather than using a conventional or traditional tethering strap. The disclosed mouth guard can be quickly removed from a user's mouth and quickly attached to a helmet component, player's finger, or other piece of equipment to allow the mouth guard to remain rigidly affixed to the player without a loose tethering strap such as used in conventional mouth guards. The invention also is applicable to other mouth guard devices which may be used for dental treatment applications to secure a dental appliance temporarily when removed from the user's mouth.

Mouth guard with fixed tether system

A metallic seal or gasket for use in the joining of cryogenic fluid conduits, the seal or gasket having a generally planar and serpentine periphery defining a central aperture. According to a preferred embodiment, the periphery has at least two opposing elongated serpentine sides and two opposing arcuate ends joining the opposing elongated serpentine sides and is of a hexagonal cross-section.

Growing community of inventors

Newtown, CT, United States of America

Timothy S Moore